CMS Lists Drugs for Next Round of Price Negotiations

One of the final acts of the Biden Administration was to publish the list of 15 drugs that will be subject to Medicare price negotiation. The list includes four oncology drugs, as well as a drug for COPD and, (drumroll…) Wegovy, the Novo Nordisk GLP-1 sensation. (Avalere)

KFF Tracking Poll: Public Likes Medicare and Medicaid

The Trump Administration campaigned on reducing federal spending in the light of continuing federal deficits. The latest polling data from KFF demonstrate that the general public would not approve of reducing spending in Medicare and Medicaid, although continuing Medicare price negotiations on drugs is popular.